Investors

Press releases

2021/09/16

Medivir invites to a conference call on new clinical data and further studies with MIV-818

Read more
2021/09/13

Abstract for MIV-818 phase 1b monotherapy for ESMO Congress published

Read more
2021/09/10

Medivir to present at the Wainwright Annual Global Investment Conference

Read more

Presentations

Quarterly report presentations

Events

2021/10/14

ProHearings Capital Markets Day

Read more
2021/11/11

Redeye Life Science Day

Read more

Corporate Governance

Medivir Corporate Governance documention.

Annual General Meeting

Documentation from Medivir's Annual General Meetings.